Coronary Artery Bypass Grafting Devices (CABG) Market By Device Type (Tissue Stabilizers, Heart Positioners, Refractors, Cannulas, Cardiopulmonary Bypass Machines And Others ), By Surgery (On Pump Or Traditional Coronary Artery Bypass Grafting, Off Pump Coronary Artery Bypass Grafting, Minimally Invasive Direct Coronary Artery Bypass Grafting), By Technique (Traditional Vessel Harvesting, Endoscopic Vessel Harvesting (EVH)) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Coronary artery bypass grafting (CABG) is a common treatment approach for coronary heart disease, which is one of the leading causes of death worldwide. Coronary artery disease occurs when oxygen-rich blood flow to the heart muscle gets constricted owing to the formation of blocking matter in the walls of the coronary arteries and further causes a heart attack or chest pain (angina). According to the records of the World Health Organization (WHO), coronary artery disease was responsible for 7.4 million deaths worldwide in the year 2015, and this global burden of cardiovascular disease is on the rise due to sedentary lifestyles and smoking, high blood pressure and cholesterol from an inappropriate diet habit, and the increasing prevalence of diabetes and obesity.

One of the common medical interventions for treating coronary artery disease includes coronary artery bypass grafting (CABG). The procedure involves grafting a healthy artery or vein to the blocked part of the coronary artery to normalize blood flow to the heart. Minimal risk, excellent outcomes, and improved long-term survival rates made CABG surgery the most preferred option for treating coronary artery disease.

The coronary artery bypass grafting market is segmented on the basis of the type of surgery performed: Off-pump or beating-heart surgery, in which grafting is performed in a beating heart using special equipment; on-pump or arrested-heart surgery, in which surgery is performed in a stopped heart using a heart-lung machine to take over the function of blood circulation, and minimally invasive direct coronary artery bypass grafting, in which the blood vessel is bypassed through a small incision. Depending on the technique followed for the CABG procedure, the market is classified as traditional vessel harvesting (TVH) or endoscopic vessel harvesting (EVH). EVH is set to take over the traditional procedure as a result of its effectiveness and success. On the basis of device types, the CABG market has been segmented as tissue stabilizers, heart positioners, refractors, cannulas, cardiopulmonary bypass machines, endoscopic vessel harvesting systems, and others. The endoscopic vessel harvesting systems segment is on the rise on account of their surging demand among surgeons as a result of successful outcomes with minimal complications.

The coronary artery bypass graft market is expected to experience substantial growth as a result of the growing prevalence of coronary artery disease. The rising geriatric population fuels the growth of the coronary artery bypass graft market by driving the prevalence of chronic diseases like high blood pressure or other cardiovascular disorders. Favorable reimbursement policies for improved medical treatment play an important role in driving the coronary artery bypass graft market. Moreover, the application of other percutaneous coronary interventions (PCI), such as angioplasty and other minimally invasive procedures, has been replacing bypass surgery in many cases and hindering the growth of the coronary artery bypass graft market.

The report "Coronary Artery Bypass Grafting Devices Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" provides detailed insights and in-depth analysis of the market with prevailing trends to achieve a global perspective of the coronary artery bypass grafting devices market. This report comprises an analysis of market dynamics, including market drivers, restraints, and opportunities, which allows industry experts to formulate business strategies. A major competitive landscape analysis of manufacturers with major partnerships, collaborations, mergers, and acquisition activities has been delivered in the study. Globally rising health concerns, an increasing prevalence of chronic ailments, and surging expenditure in research to develop new products boost the growth of the coronary artery bypass grafting devices market. This report offers market size and forecasts for every stated section with cross-sectional analysis for the duration of 2015–2025, along with corresponding CAGRs for the forecast period of 2017–2025.

Based on geography, the coronary artery bypass grafting devices market is presented as five major areas, which are further segmented as follows:

  • North America
    • The United States
    • Canada
  • Europe
    • The United Kingdom
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • rest of Latin America
  • Middle East and Africa
    • Gulf Cooperation Council (GCC)
    • Rest of the Middle East and Africa

This research report provides a brief overview of the major market players in the global coronary artery bypass grafting devices market, including Terumo Corporation, Medtronic, MAQUET Holding B.V. & Co.KG, Saphena Medical, Inc., Sorin Group, Vitalitec International, Inc., AtriCure, Inc., Edwards Lifesciences, Genesee Biomedical Inc., KARL STORZ GmbH & Co. K.G., Transonic, and others.

Based on devices deployed in coronary artery bypass graft (CABG) surgical procedures, the market is categorized on the following basis:

  • Tissue stabilizer
  • Heart Positioner
  • Refractor
  • Cannula
  • Cardiopulmonary bypass machines
  • endoscopic vessel harvesting system
  • Others

Tissue stabilizers and heart positioners have a massive role in the off-pump coronary artery bypass graft procedure to immobilize the heart. The preference for off-pump CABG procedures is high owing to the clinical advantages, which increase the usage of tissue stabilizers and heart positioners in order to accomplish successful treatment. The market for coronary artery bypass grafts is rising with the increasing usage of endoscopic vessel harvesting systems in bypass grafting procedures. With the recent advancement of technology, the scope of risks and complications has been reduced, while the use of endoscopic vessel harvesting systems in surgeries has made these devices more preferred among surgeons. During on-pump coronary artery bypass grafting, a cardiopulmonary bypass machine is used to take over the functions of the heart and lungs. These devices are currently experiencing huge demand on account of the high number of coronary artery bypass graft procedures performed in medical facilities. However, its demand is expected to diminish in the coming years due to associated risks and infections.

On the basis of surgical procedures, the coronary artery bypass grafting devices market is categorized on the following basis:

  • On-Pump or Traditional Coronary Artery Bypass Grafting
  • Off-Pump Coronary Artery Bypass Grafting
  • Minimally invasive direct coronary artery bypass grafting

On-pump or traditional coronary artery bypass grafting is the predominant segment where the chest is opened to gain access for intervention, and a heart-lung machine is attached for blood and oxygen flow. More familiarity with this procedure among surgeons makes it the leading segment and preferred procedure. On-pump coronary artery bypass grafts avoid repeat revascularization, which subsequently raised their demand among medical professionals. The increasing number of cardiac emergencies increases the usage of on-pump coronary artery bypass grafting in healthcare facilities.

The market share of off-pump bypass grafts is increasing due to the low risk of infection and morbidity because they are performed without the use of any heart-lung machines. Off-pump bypass grafting shows significant benefits, such as a shorter recovery time than traditional coronary artery bypass grafting, minimal blood loss, a reduced inflammatory response, and fewer postoperative complications. Lower morbidity and mortality rates associated with the off-pump CABG procedure increase its demand.

Minimally invasive coronary artery bypass grafting is an alternative to traditional coronary artery bypass grafts, where a small incision is made to gain access to the coronary arteries that need to be grafted. The rising demand for this procedure is due to the lower risk of infection and complication, the minimal scar, and increased patient satisfaction. However, minimally invasive coronary artery bypass grafting is not suitable for multiple diseased vessels, and this limitation might hinder the growth of minimally invasive direct coronary artery bypass grafting.

Based on the technique followed, the coronary artery bypass grafting devices market is classified on the following basis:

  • Traditional Vessel Harvesting
  • Endoscopic Vessel Harvesting (EVH)

In traditional vessel harvesting, a longer incision is made for the removal of the vessel to be used for bypass grafting, and it leaves an extended scar and further wound complications. Traditional vessel harvesting is expected to lose market share due to the increasing demand for the endoscopic vessel harvesting (EVH) technique. Endoscopic vessel harvesting is likely to gain considerable acceptance in the coming years as a result of minimal complications like infections, scar and hematoma formation, smaller leg wounds, and a shorter recovery time. In the United States, around 80% of coronary artery bypass grafts are performed using the EVH technique. In the EVH procedure, a smaller incision is made to remove the blood vessel using surgical and video equipment. Endoscopic vessel harvesting is anticipated to take over the coronary artery bypass grafting devices market in the future due to overall lower medical costs, shorter hospital stays, and successful results. Endoscopic vessel harvesting procedures are driven by the benefits of a faster focus on cardiac rehabilitation after bypass grafting, higher patient satisfaction, and less postoperative pain.

Geographically, the global coronary artery bypass grafting devices market is cumulative for North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.

North America is estimated to lead the coronary artery bypass grafting devices market with maximum revenue, followed by Europe. According to the data from the American Heart Association, heart disease is the leading cause of death in the United States, where coronary heart disease alone is responsible for killing more than 360,000 people a year. The medical cost of coronary heart disease was U.S. $ 10.4 billion in 2017, and this figure is expected to rise by 100% in the coming years, supporting the significant growth of the coronary artery bypass grafting devices market in North America. Coronary artery bypass grafting is a commonly performed procedure in the United States, with nearly 400,000 procedures per year. The American Heart Association has committed to funding 980 new research projects worth $163 million, and this increasing research expenditure is also driving the growth of the coronary artery bypass grafting devices market in the United States. Moreover, an increasing geriatric population, a growing number of chronic cardiac disorders, and the rising prevalence of high blood pressure and diabetes are some of the key factors propelling the growth of the coronary artery bypass grafting devices market in this region. As per the records of the British Heart Foundation, more than 2.3 million people are suffering from coronary heart disease in the United Kingdom, and this number is on the rise due to sedentary lifestyles and smoking habits in Europe.

Asia Pacific is projected to witness lucrative growth in the coming years on account of a rising elderly population and the increasing prevalence of hypertension, obesity, and diabetes, which further lead to coronary artery disorders.

The detailed regional classification of the global coronary artery bypass grafting devices market is as follows:

  • North America (Canada and the United States)
  • Europe (the United Kingdom, Germany, and the rest of Europe)
  • Asia Pacific (Japan, China, India, and the Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, and the Rest of Latin America)
  • Middle East and Africa (GCC and the rest of the Middle East and Africa)

Frequently Asked Questions:

The market for Coronary Artery Bypass Grafting Devices is expected to reach US$ XX in 2025.

The Coronary Artery Bypass Grafting Devices market is expected to see significant CAGR growth over the coming years,at 5.5%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

AtriCure, Inc.,Edwards Lifesciences,Genesee Biomedical Inc.,KARL STORZ GmbH & Co. KG,MAQUET Holding B.V. & Co.KG, are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Nov 2017
Category:  Medical Devices
Report ID:   58856
Report Format:   PDF
Pages:   120
Rating:    4.7 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support